NLS Pharmaceutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLSP and other ETFs, options, and stocks.About NLSP
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder.
CEOAlexander C. Zwyer
CEOAlexander C. Zwyer
Employees4
Employees4
HeadquartersZurich, Zurich
HeadquartersZurich, Zurich
Founded2015
Founded2015
Employees4
Employees4
NLSP Key Statistics
Market cap3.98M
Market cap3.98M
Price-Earnings ratio-8.51
Price-Earnings ratio-8.51
Dividend yield—
Dividend yield—
Average volume29.06K
Average volume29.06K
High today$1.63
High today$1.63
Low today$1.60
Low today$1.60
Open price$1.62
Open price$1.62
Volume11.61K
Volume11.61K
52 Week high$18.39
52 Week high$18.39
52 Week low$1.30
52 Week low$1.30
People also own
Based on the portfolios of people who own NLSP. This list is generated using Robinhood data, and it’s not a recommendation.